Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)

NCT05572970 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Balstilimab
DRUG: Zalifrelimab

Sponsor

Agenus Inc.